RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.42B
AUM Growth
-$513M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
73
New
Increased
Reduced
Closed

Top Buys

1
+$107M
2
+$60.8M
3
+$53.5M
4
GERN icon
Geron
GERN
+$52.9M
5
PLRX icon
Pliant Therapeutics
PLRX
+$50.2M

Top Sells

1
+$83.8M
2
+$52.6M
3
+$25M
4
DALS
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
+$15M
5
CLDX icon
Celldex Therapeutics
CLDX
+$14.7M

Sector Composition

1 Healthcare 99.99%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$14.4M 0.32%
1,400,001
52
$9.91M 0.22%
3,370,506
53
$6.99M 0.16%
6,991,003
54
$4.89M 0.11%
2,589,904
55
$4.27M 0.1%
590,218
56
$4.13M 0.09%
5,914,252
57
$2.49M 0.06%
659,992
58
$613K 0.01%
333,333
59
$343K 0.01%
295,966
60
– –
-1,500,000
61
– –
-958,980
62
– –
-188,130
63
– –
-275,000
64
– –
-195,896
65
– –
-1,127,260
66
– –
-610,283
67
– –
-1,856,904
68
– –
-534,687
69
– –
-3,984,681
70
– –
-1,607,834
71
– –
-1,000,000
72
– –
-1,088,296
73
– –
-632,184
1 2
3